254 related articles for article (PubMed ID: 30759696)
1. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
Morgan SC; Hoffman K; Loblaw DA; Buyyounouski MK; Patton C; Barocas D; Bentzen S; Chang M; Efstathiou J; Greany P; Halvorsen P; Koontz BF; Lawton C; Leyrer CM; Lin D; Ray M; Sandler H
J Urol; 2019 Mar; 201(3):528-534. PubMed ID: 30759696
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.
Morgan SC; Hoffman K; Loblaw DA; Buyyounouski MK; Patton C; Barocas D; Bentzen S; Chang M; Efstathiou J; Greany P; Halvorsen P; Koontz BF; Lawton C; Leyrer CM; Lin D; Ray M; Sandler H
Pract Radiat Oncol; 2018; 8(6):354-360. PubMed ID: 30322661
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Smith BD; Bellon JR; Blitzblau R; Freedman G; Haffty B; Hahn C; Halberg F; Hoffman K; Horst K; Moran J; Patton C; Perlmutter J; Warren L; Whelan T; Wright JL; Jagsi R
Pract Radiat Oncol; 2018; 8(3):145-152. PubMed ID: 29545124
[TBL] [Abstract][Full Text] [Related]
4. Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.
Deville C; Kamran SC; Morgan SC; Yamoah K; Vapiwala N
Pract Radiat Oncol; 2024; 14(1):47-56. PubMed ID: 38182303
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Radiotherapy for Localized Prostate Cancer: When and for Whom?
Roy S; Morgan SC
Curr Urol Rep; 2019 Jul; 20(9):53. PubMed ID: 31359187
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
[TBL] [Abstract][Full Text] [Related]
7. Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.
McClelland S; Sandler KA; Degnin C; Chen Y; Hung AY; Mitin TE
Int Braz J Urol; 2019; 45(2):273-287. PubMed ID: 30676300
[TBL] [Abstract][Full Text] [Related]
8. Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Shelan M; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Müller AC; Niehoff P; Pinkawa M; Schmidt-Hegemann NS; Sedlmayer F; Wolf F; Zamboglou C; Zips D; Wiegel T; Ghadjar P
Strahlenther Onkol; 2021 Nov; 197(11):993-1000. PubMed ID: 34463814
[TBL] [Abstract][Full Text] [Related]
9. Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Wolf F; Sedlmayer F; Aebersold D; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Ghadjar P; Höcht S; Hölscher T; Müller AC; Niehoff P; Pinkawa M; Schmidt-Hegemann NS; Zamboglou C; Zips D; Wiegel T
Strahlenther Onkol; 2021 Feb; 197(2):89-96. PubMed ID: 33301049
[TBL] [Abstract][Full Text] [Related]
10. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.
Likhacheva A; Awan M; Barker CA; Bhatnagar A; Bradfield L; Brady MS; Buzurovic I; Geiger JL; Parvathaneni U; Zaky S; Devlin PM
Pract Radiat Oncol; 2020; 10(1):8-20. PubMed ID: 31831330
[TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.
Palta M; Godfrey D; Goodman KA; Hoffe S; Dawson LA; Dessert D; Hall WA; Herman JM; Khorana AA; Merchant N; Parekh A; Patton C; Pepek JM; Salama JK; Tuli R; Koong AC
Pract Radiat Oncol; 2019; 9(5):322-332. PubMed ID: 31474330
[TBL] [Abstract][Full Text] [Related]
12. Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline.
Moeller B; Balagamwala EH; Chen A; Creach KM; Giaccone G; Koshy M; Zaky S; Rodrigues G
Pract Radiat Oncol; 2018; 8(4):245-250. PubMed ID: 29625898
[TBL] [Abstract][Full Text] [Related]
13. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
14. Important Technical Considerations for Implementing the ASTRO/ASCO/AUA Prostate Cancer Hypofractionated Radiation Guideline.
LaRiviere MJ; Zhu TC; Christodouleas JP
Pract Radiat Oncol; 2019; 9(4):197-199. PubMed ID: 30836189
[No Abstract] [Full Text] [Related]
15. Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002.
Vargas CE; Hartsell WF; Dunn M; Keole SR; Doh L; Eisenbeisz E; Larson GL
Am J Clin Oncol; 2018 Feb; 41(2):115-120. PubMed ID: 26523442
[TBL] [Abstract][Full Text] [Related]
16. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.
Wo JY; Anker CJ; Ashman JB; Bhadkamkar NA; Bradfield L; Chang DT; Dorth J; Garcia-Aguilar J; Goff D; Jacqmin D; Kelly P; Newman NB; Olsen J; Raldow AC; Ruiz-Garcia E; Stitzenberg KB; Thomas CR; Wu QJ; Das P
Pract Radiat Oncol; 2021; 11(1):13-25. PubMed ID: 33097436
[TBL] [Abstract][Full Text] [Related]
17. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
Kaidar-Person O; Roach M; Créhange G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.
Tramacere F; Arcangeli S; Pignatelli A; Castagna R; Portaluri M
Anticancer Res; 2015 May; 35(5):3049-54. PubMed ID: 25964594
[TBL] [Abstract][Full Text] [Related]
19. What is the best way to radiate the prostate in 2016?
Moon DH; Efstathiou JA; Chen RC
Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453
[TBL] [Abstract][Full Text] [Related]
20. External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline.
Apisarnthanarax S; Barry A; Cao M; Czito B; DeMatteo R; Drinane M; Hallemeier CL; Koay EJ; Lasley F; Meyer J; Owen D; Pursley J; Schaub SK; Smith G; Venepalli NK; Zibari G; Cardenes H
Pract Radiat Oncol; 2022; 12(1):28-51. PubMed ID: 34688956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
